Your browser doesn't support javascript.
loading
Postoperative Chemotherapy Use and Outcomes From ADAURA: Osimertinib as Adjuvant Therapy for Resected EGFR-Mutated NSCLC.
Wu, Yi-Long; John, Thomas; Grohe, Christian; Majem, Margarita; Goldman, Jonathan W; Kim, Sang-We; Kato, Terufumi; Laktionov, Konstantin; Vu, Huu Vinh; Wang, Zhijie; Lu, Shun; Lee, Kye Young; Akewanlop, Charuwan; Yu, Chong-Jen; de Marinis, Filippo; Bonanno, Laura; Domine, Manuel; Shepherd, Frances A; Zeng, Lingmin; Atasoy, Ajlan; Herbst, Roy S; Tsuboi, Masahiro.
Afiliación
  • Wu YL; Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital and Guangdong Academy of Medical Sciences, Guangzhou, People's Republic of China. Electronic address: syylwu@live.cn.
  • John T; Department of Medical Oncology, Austin Health, Melbourne, Australia.
  • Grohe C; Department of Respiratory Diseases, Evangelische Lungenklinik, Berlin, Germany.
  • Majem M; Department of Medical Oncology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
  • Goldman JW; David Geffen School of Medicine at University of California, Los Angeles, California.
  • Kim SW; Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.
  • Kato T; Department of Thoracic Oncology, Kanagawa Cancer Center, Yokohama, Japan.
  • Laktionov K; Federal State Budgetary Institution N.N. Blokhin National Medical Research Center of Oncology of the Ministry of Health of the Russian Federation (N.N. Blokhin NMRCO), Moscow, Russia.
  • Vu HV; Department of Thoracic Surgery, Choray Hospital, Ho Chi Minh City, Vietnam.
  • Wang Z; State Key Laboratory of Molecular Oncology, Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, People's Republic of China.
  • Lu S; Lung Cancer Center, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, People's Republic of China.
  • Lee KY; Precision Medicine Lung Cancer Center, Konkuk University Medical Center, Seoul, South Korea.
  • Akewanlop C; Division of Medical Oncology, Faculty of Medicine, Siriraj Hospital, Bangkok, Thailand.
  • Yu CJ; Department of Internal Medicine, National Taiwan University Hospital Hsinchu Branch and National Taiwan University College of Medicine, Taipei, Taiwan.
  • de Marinis F; Thoracic Oncology Division, European Institute of Oncology (IEO), IRCCS, Milan, Italy.
  • Bonanno L; Medical Oncology 2, Istituto Oncologico Veneto IOV IRCCS, Padova, Italy.
  • Domine M; Oncology Department, Instituto de Investigación Sanitaria-Fundación Jiménez Díaz, Madrid, Spain.
  • Shepherd FA; Department of Medical Oncology and Hematology, University Health Network, Princess Margaret Cancer Centre and the University of Toronto, Toronto, Ontario, Canada.
  • Zeng L; Late Oncology Statistics, AstraZeneca, Gaithersburg, Maryland.
  • Atasoy A; Late Oncology Research & Development, AstraZeneca, Cambridge, United Kingdom.
  • Herbst RS; Medical Oncology, Yale School of Medicine and Yale Cancer Center, New Haven, Connecticut.
  • Tsuboi M; Department of Thoracic Surgery and Oncology, National Cancer Center Hospital East, Kashiwa, Japan.
J Thorac Oncol ; 17(3): 423-433, 2022 03.
Article en En | MEDLINE | ID: mdl-34740861
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Carcinoma de Pulmón de Células no Pequeñas / Neoplasias Pulmonares Tipo de estudio: Clinical_trials Límite: Humans Idioma: En Revista: J Thorac Oncol Año: 2022 Tipo del documento: Article
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Carcinoma de Pulmón de Células no Pequeñas / Neoplasias Pulmonares Tipo de estudio: Clinical_trials Límite: Humans Idioma: En Revista: J Thorac Oncol Año: 2022 Tipo del documento: Article